CONTINUCARE CORP (CNU) [Rocket]

Overview

CONTINUCARE CORP (CNU)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
11/01/2011	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]
10/27/2011	10-K/A	Annual Report for the period ended June 30, 2011 [amend]
10/24/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/24/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/24/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/24/2011	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/12/2011	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Jun-30-11	Jun-30-10	Jun-30-09	Jun-30-08	Jun-30-07	Jun-30-06	Jun-30-04
Revenues	333.5	310.8	281.3	254.4	217.1	133.0	101.8
Revenue growth	7.3%	10.5%	10.5%	17.2%	63.3%		4.8%
Cost of goods sold	22.1	18.0	16.3	0.0	0.0	0.0	0.0
Gross profit	311.3	292.8	265.0	254.4	217.1	133.0	101.8
Gross margin	93.4%	94.2%	94.2%	100.0%	100.0%	100.0%	100.0%
General and administrative	22.1	18.0	16.3	16.4	14.0	7.6	5.8
EBIT	37.4	36.1	24.7	17.9	9.9	7.9	5.0
EBIT margin	11.2%	11.6%	8.8%	7.0%	4.6%	6.0%	4.9%
Pre-tax income	37.6	36.1	24.9	18.4	10.2	8.3	6.2
Income taxes	13.7	13.9	9.6	7.1	3.9	2.9	0.0
Tax rate	36.4%	38.5%	38.6%	38.8%	38.2%	35.4%	0.0%
Earnings from continuing ops	23.9	22.2	15.3	11.3	6.3	5.3	6.2
Earnings from discontinued ops							4.7
Net income	23.9	22.2	15.3	11.3	6.3	5.3	10.9
Net margin	7.2%	7.1%	5.4%	4.4%	2.9%	4.0%	10.7%

Diluted EPS	$0.38	$0.36	$0.24	$0.16	$0.10	$0.10	$0.13
Shares outstanding (diluted)	62.4	61.6	62.5	70.0	66.3	51.2	49.2

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.